ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO1085

Association Between Dialysate Sodium Concentration and Interdialytic Weight Gain in Patients Undergoing Twice Weekly Haemodialysis

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis


  • Manji, Soraiya, Aga Khan University - Kenya, Nairobi, Kenya
  • Shah, Jasmit, Aga Khan University - Kenya, Nairobi, Kenya
  • Twahir, Ahmed, Aga Khan University - Kenya, Nairobi, Kenya
  • Sokwala, Ahmed Parwizali, Aga Khan University - Kenya, Nairobi, Kenya

Chronic kidney disease is highly prevalent in the world with more than two million people worldwide requiring renal replacement therapy. Interdialytic weight gain is the change in body weight between two sessions of haemodialysis. Higher interdialytic weight gain has been associated with increased mortality and adverse cardiovascular outcomes. It has long been questioned whether using a lower dialysate sodium concentration during dialysis would reduce the interdialytic weight gain and prevent these adverse outcomes.


This was a single blind cross-over study of adult patients undergoing twice weekly haemodialysis conducted over two six week periods. Patients were divided into two groups – the first underwent dialysis with dialysate sodium concentration of 137meq/l, the other underwent dialysis with a sodium concentration of 140meq/l. These groups switched over after a six-week period without a washout period. Interdialytic weight gain, pre and post dialysis blood pressures were measured at each dialysis session.


41 patients were included in the primary analysis after meeting inclusion criteria. Mean age was 61.37 years, and 73% were males. Mean duration for dialysis was 2.53 years. 13% were anuric, 56% were oliguric, and 31% were non-oliguric. 59% of patients had diabetes mellitus and 80% had hypertension. The interdialytic weight gain was not significantly different among the two groups (2.14 for the low DNa (137meq/l) group and 2.35 for the high DNa (140meq/l) group, p = 0.97). Mean blood pressures were as follows. Pre-dialysis: DNa 137meq/l: systolic 152.14 ± 19.99, diastolic 78.99 ± 12.20, DNa 140meq/l: systolic 156.95 ± 26.45, diastolic 79.75 ± 11.25 (p = 0,379, 0.629 respectively). Post-dialysis: DNa 137meq/l: systolic 147.29 ± 22.22, diastolic 77.85 ± 12.82 DNa 140meq/l: systolic 151.48 ± 25.65, diastolic 79.66 ± 15.78 (p = 0,569, 0.621 respectively).


There was no significant difference in the interdialytic weight gain as well as pre dialysis and post dialysis systolic and diastolic blood pressures between the low dialysate sodium concentration and high dialysate sodium concentration. Therefore using a lower dialysate sodium concentration does not appear useful in altering the interdialytic weight gain although further studies with a larger sample size are warranted.